<DOC>
	<DOCNO>NCT02194569</DOCNO>
	<brief_summary>Rationale : A high citrate dose continuous venovenous hemofiltration provide good anticoagulation possibly high risk citrate accumulation case metabolic limitation . A high citrate dose also increase magnesium loss ultrafiltrate , negative magnesium balance unwanted . Objective : Aim study determine magnesium balance citrate-based continuous veno-venous hemofiltration ( CVVH ) determine whether extent magnesium balance depend citrate dose . Study design method : A prospective randomized study conduct critically ill patient acute kidney injury ( AKI ) , treat CVVH , either low dose citrate ( 2.5 mmol/L blood flow filter ) high dose citrate ( 4.5 mmol/L blood flow filter ) anti-coagulant , target postfilter ionize Calcium ( iCa ) resp . 1.3-1.6 mg/dL ( 0.325-0.4 mmol/L ) 0.8-1.1 mg/dL ( 0.2-0.275 mmol/L ) . Post-filter blood well effluent aliquot bloodconcentrations patient test following variable : ( 0 , 2 , 4 , 6 , 12 24 hr ) : Total Magnesium ( tMg ) total Calcium ( tCa ) , ionize Ca ( iCa ) ( bloodgas analyzer ) . In addition , hematocrit , albumin , total protein , ureum creatinine parathormone ( PTH ) determine arterial blood 0 24 hr time protocol exit citrate concentration postfilter arterial blood 1 24 hr protocol exit . Sample site : arterial line , postfilter port ( postdilution calcium compensation ) , effluent sample . All flow rate note . Study population : Twenty patient admit intensive care , require continuous renal replacement therapy ( CRRT ) AKI . Intervention : Anti-coagulation either low dose citraat ( 2.5 mmol/L blood flow ) high dose citraat ( 4.5 mmol/L blood flow ) target postfilter iCa resp . 1.3-1.6 0.8-1.1 mg/dL . Both regimen within standard protocolled CVVH treatment intensive care department .</brief_summary>
	<brief_title>Magnesium Balance Citrate-based Continuous Venovenous Hemofiltration , Effect Citrate Dose .</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Critically ill patient require CRRT AKI ( RIFLE criterion ) Written informed consent patient legal representative preexist chronic renal insufficiency require dialysis chronic immunosuppression liver cirrhosis ChildPugh C severe shockrelated hepatitis Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>